Verona Pharma PLC (VRNA)
37.86
-0.99
(-2.55%)
USD |
NASDAQ |
Nov 21, 16:00
38.93
+1.07
(+2.83%)
Pre-Market: 09:14
Verona Pharma Shareholders Equity (Quarterly): 130.49M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 130.49M |
| June 30, 2024 | 168.27M |
| March 31, 2024 | 224.99M |
| December 31, 2023 | 249.28M |
| September 30, 2023 | 263.53M |
| June 30, 2023 | 273.09M |
| March 31, 2023 | 276.75M |
| December 31, 2022 | 230.47M |
| September 30, 2022 | 237.48M |
| June 30, 2022 | 110.88M |
| March 31, 2022 | 126.31M |
| December 31, 2021 | 148.00M |
| September 30, 2021 | 168.20M |
| June 30, 2021 | 154.40M |
| March 31, 2021 | 172.41M |
| December 31, 2020 | 184.85M |
| September 30, 2020 | 197.72M |
| June 30, 2020 | 23.62M |
| March 31, 2020 | 31.94M |
| December 31, 2019 | 42.74M |
| September 30, 2019 | 49.52M |
| June 30, 2019 | 63.14M |
| March 31, 2019 | 75.80M |
| December 31, 2018 | 80.47M |
| September 30, 2018 | 84.95M |
| Date | Value |
|---|---|
| June 30, 2018 | 87.35M |
| March 31, 2018 | 92.01M |
| December 31, 2017 | 107.95M |
| September 30, 2017 | 114.17M |
| June 30, 2017 | 121.23M |
| December 31, 2016 | 42.53M |
| June 30, 2016 | 5.562M |
| June 30, 2016 | 5.562M |
| December 31, 2015 | 8.050M |
| June 30, 2015 | 14.43M |
| June 30, 2015 | 14.43M |
| December 31, 2014 | 19.62M |
| June 30, 2014 | 23.60M |
| June 30, 2014 | 23.60M |
| December 31, 2013 | 3.410M |
| June 30, 2013 | 3.994M |
| June 30, 2013 | 3.994M |
| December 31, 2012 | 4.207M |
| June 30, 2012 | 6.336M |
| June 30, 2012 | 6.336M |
| December 31, 2011 | 6.289M |
| June 30, 2011 | 4.242M |
| December 31, 2010 | 5.326M |
| June 30, 2010 | 6.765M |
| December 31, 2009 | 7.247M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
23.62M
Minimum
Jun 2020
276.75M
Maximum
Mar 2023
170.77M
Average
170.34M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 11.04M |
| TC BioPharm (Holdings) PLC | 1.364M |
| Adaptimmune Therapeutics PLC | 79.99M |
| NuCana PLC | 4.806M |
| Autolus Therapeutics PLC | 476.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 381.82M |
| Total Liabilities (Quarterly) | 251.33M |
| Debt to Equity Ratio | 0.9197 |
| Current Ratio | 13.03 |
| Net Debt Paydown Yield | -0.85% |